FDA DEVICE FACTS
INHANCE™ Reverse Shoulder System
Depuy Ireland UC
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
Anatomic Total Shoulder or Hemi-Shoulder The INHANCE SHOULDER SYSTEM with the humeral stemless anchor is intended for use in anatomic total shoulder replacement procedures to address the following: r that do not compromise the fixation The INHANCE SHOULDER SYSTEM with a humeral stem is intended for use in anatomic total or hemi-shoulder replacement procedures to address the following: ease including osteoarthritis and avascular necrosis. or treatments have failed. ead (with Short Humeral Stems) humerus, where other methods of treatment are deemed inadequate (with Standard or Long Stems) ere other methods of treatment may not be suitable or may be inadequate. Fixation Methods The humeral stems are intended for cemented or cementless use. The humeral stemless anchor is intended for cementless use. The glenoid is intended for cemented use only. Reverse Total Shoulder The INHANCE SHOULDER SYSTEM Reverse Total Shoulder with a humeral stem is indicated for primary, fracture or revision total reverse shoulder replacement procedures to address the following. The system is indicated for use in patients whose shoulder joint has a gross rotator cuff deficiency. The patient must be anatomically and structurally suited to receive the implants and a functional deltoid muscle is necessary. The system is also indicated for conversion from an anatomic to reverse shoulder prosthesis without the removal of a well-fixed INHANCE humeral stem. disabling, arthritic joint ead (with Short Humeral Stems) s (with Standard or Long Stems) ed shoulder joint replacements Fixation Methods The humeral stem is intended for cemented or cementless use. The glenoid baseplate components are intended for cementless application with the addition of screw fixation. Summary of Technologies/Substantial Equivalence: The implant and associated instruments within the INHANCETM Reverse Shoulder System are substantially equivalent to the predicate devices in terms to its intended use and indications, material, design, sizes, and mechanical properties. Differences between the subject device system and the predicate device systems do not raise different questions of safety and effectiveness. Non-Clinical Testing: The INHANCE TM Reverse Shoulder System underwent non-clinical testing and analyses to support a determination of substantial equivalence to the predicate device. The following were completed: Range of Motion (RoM) Evaluation An evaluation was conducted to ensure the RoM of the worst-case subject device components meet established specifications per ASTM F1378. The RoM targets were met. Construct Fatigue Testing Construct fatigue testing was performed per ASTM F1378. The acceptance criteria were met. Construct Loosening and Disassociation The INHANCETM Reverse Shoulder System was evaluated for loosening and disassociation per ASTM F2028-17. The acceptance criteria were met. Biocompatibility Assessments The contact classification for the subject devices is Implant, Bone/Tissue with permanent contact (>30 days). A Biocompatibility Assessments was completed and provided per ISO 10993-1 and FDA Guidance Document Use of International Standard ISO 10993-1, "Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process". The devices were found to be biocompatible. Porous Structure Characterization The porous structure used for the subject device is identical to the porous structure that was applied to the implants cleared under K202716 (Ignite Anatomic Shoulder System) and K203108 (Ignite Stemless Anatomic Shoulder System). Characterization of VE-UHMWPE The Vitamin E Ultra High Molecular Weight Polyethylene (Cross-linked, VE UHMWPE) material used for the Liners of the INHANCETM Reverse Shoulder is identical to the VE UHMWPE material that was used on the devices cleared under K202716 (Ignite Anatomic Shoulder System). The material was fully characterized per FDA Guidance, "Characterization of Ultrahigh Molecular Weight Polyethylene (UHMWPE) Used in Orthopedic Devices-Guidance for Industry and Food and Drug Administration Staff" in K202716. Evaluation of Wear Rate Wear testing of the Vit-E UHMWPE liners was completed on a joint simulator under pristine and abrasive conditions. Prior to wear testing, the liners were accelerated aged per ASTM F2003. The resulting wear rate was lower than that of a predicate device. The acceptance criteria were met. Micro-CT assessment of wear features on the humeral liners was conducted following abrasive wear testing. MRI Compatibility Quantitative data was obtained to inform Magnetic Resonance Imaging (MRI) Conditional Labeling through the following evaluations: Force: Static Magnetic Field Induced Displacement Force per ASTM F2052-15 Torque: Static Magnetic Field Induced Torque per ASTM F2213-17 Heating: Radiofrequency field (RF) induced heating per ASTM F2182-19e2 Image Quality: Susceptibility induced image artifacts per ASTM F2119-07 Shelf Life Evaluation A shelf life evaluation per ISO 11607-1 and ISO 11607-2 was completed on the packaging materials that make up the sterile barrier. A five-year shelf life was established based on the resultant data. Sterilization Validation Sterilization validation was completed using the VDmax method specified in ISO 11137-1 and ISO 11137-2. The Sterility Assurance Level (SAL) was found to be 10 -6. Clinical Testing: Clinical testing was not necessary to demonstrate substantial equivalence of the INHANCETM Reverse Shoulder System to the predicate devices.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。